drugset
drugset / Trial / NCT03686813

Sildenafil for Swimming-Induced Pulmonary Edema (SIPE) Prevention

NCT03686813 ↗

Phase 2 Completed 18 enrolled Duke University United States Department of Defense · collab
RandomizedCrossoverQuadruple-blindPrevention

Summary

This trial is testing the effectiveness of a single oral dose of sildenafil (50 mg) taken 1 hour before a provocative event on the subsequent development of swimming-induced pulmonary edema.

Timeline

Start
2019-07-15
Primary completion
2021-10-29
Completion
2021-10-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown 50 mg Oral

Indications

pulmonary edema